A COMPARATIVE STUDY OF PREVALENCE OF HCV BY RAPID DIAGNOSTIC TEST KIT AND ELISA IN A TERTIARY CARE HOSPITAL, ANDHRA PRADESH
DOI:
https://doi.org/10.22159/ijcpr.2025v17i2.6073Keywords:
Prevalence of HCV, Rapid diagnostic test KitAbstract
Objective: Hepatitis C Virus (HCV) is an enveloped single-stranded RNA virus transmitted through exposure to small quantities of blood and most commonly through blood transfusion. For diagnosing hepatitis C infection, serologic assays are the most important tools which detect the human antibodies generated as a response to hepatitis C virus. We aim to estimate the prevalence of HCV in a Tertiary care hospital. To assess the Seroprevalence of HCV by Rapid Diagnostic Test (RDT). To assess the Seroprevalence of HCV by ELISA. To compare the Sensitivity and Specificity of RDT with ELISA. Methods: A total of 360 serum samples were collected from patients attending outpatient departments over a period of 12 mo. These samples were tested for HCV antibody using a commercially available ELISA kit and Rapid Diagnostic Test (RDT) Kit according to the instructions provided in the manufacturer’s manual. Results: Among the 360 samples tested, 28 samples were positive by ELISA whereas only 20 were positive by Rapid Diagnostic test kit. Majority of the samples collected were in the age group of 21-30 yrs. Positive cases were almost equally distributed in all age groups. Conclusion: The present study highlights currents cenario of HCV infection in a tertiary care hospital. RDT, though showed 100% specificity, the sensitivity was only 71.43%. It missed 8 positive cases. Hence we cannot rely on rapid tests. But as they are simple to perform, rapid and cheap, their use can be restricted only to emergency situations.
Downloads
References
Aceijas C, Rhodes T. Global estimates of prevalence of HCV infection among injecting drug users. Int J Drug Policy. 2007;18(5):352-8. doi: 10.1016/j.drugpo.2007.04.004, PMID 17854722.
Shekhar S. Hepatitis C virus infection in the Indian sub-continent. In: hepatitis C in developing countries. Amsterdam: Elsevier; 2018. p. 83-95. doi: 10.1016/B978-0-12-803233-6.00008-4.
Papatheodoridis GV, Tsochatzis E, Hardtke S, Wedemeyer H. Barriers to care and treatment for patients with chronic viral hepatitis in Europe: a systematic review. Liver Int. 2014;34(10):1452-63. doi: 10.1111/liv.12565, PMID 24750532.
Hedskog C, Parhy B, Chang S, Zeuzem S, Moreno C, Shafran SD. Identification of 19 novel hepatitis C virus subtypes further expanding HCV classification. Open Forum Infect Dis. 2019 Feb 22;6(3):ofz076. doi: 10.1093/ofid/ofz076, PMID 30949527.
Kim MH, Kang SY, Lee WI. Evaluation of a new rapid test kit to detect hepatitis C virus infection. J Virol Methods. 2013;193(2):379-82. doi: 10.1016/j.jviromet.2013.07.005, PMID 23871756.
Cloherty GA, Young TP, Lucic D, Steinhart C, Letendre S. Dried blood spots (DBS) for hepatitis C (HCV) molecular diagnostic testing. J Hepat Res. 2014;1(3):1017.
Salmani MP, Peerapur BV. Seroprevalance of hepatitis C among hospital-based general population in Bijapur Karnataka India. Int J Biopharm Res. 2014;3(3):204-6.
Kumar M, Verma RK, Singh M, Nirjhar S, Chaudhary R. Seroprevalance of HCV infection at a Tertiary Care Hospital Western Uttar Pradesh, India. Int J Res Rev. 2019;6(4):1-5.
Mahgoub A, El Imad T, Al Moussawi H, Daneshvar D, Haddad FG, Saabiye J. Hepatitis C infection patterns at a Tertiary Care Center in New York: a cross-sectional study. Cureus. 2018;10(2):e2225. doi: 10.7759/cureus.2225, PMID 29713570.
Khan M, Khan S, Haider S, Jalil F, Jamal M, Ahmad A. Prevalence and risk factors of hepatitis C virus (HCV) in Tehsil Batkhela District Malakand, KPK, Pakistan. Int J Cont Res Rev. 2018;9(6):20251-6. doi: 10.15520/ijcrr/2018/9/06/525.
Patil SR, Ghorpade MV. Seroprevalence of antibodies to the hepatitis C virus in a hospital-based population: a study from western Maharashtra, India. Int J Collab Res Intern Med Public Health. 2014;6(4):102-8.
Rajani M, Jais M. Age-wise seroprevalence of hepatitis C virus infection in clinically suspected infectious hepatitis patients attending a Tertiary Care Hospital in Delhi. Int J Med Public Health. 2014;4(1):78-81. doi: 10.4103/2230-8598.127163.
Singh RM, Huidrom S, Dutta S, Sadhukhan PC, Singh KL. Comparative evaluation of three diagnostic tools for the detection of hepatitis C virus among high-risk individuals in a Tertiary Care Centre of Northeast India. J Clin Diagn Res. 2022;16(7):DC13-DC17. doi: 10.7860/JCDR/2022/56521.16610.
Arora SK, Chhabra M, Anuradha A, Achra A, Duggal N. Comparison of fourth generation elisa and rapid diagnostic test for diagnosis of hepatitis c virus(HCV) infection in a Tertiary Care Hospital. PIJR. 2021:15-7. doi: 10.36106/2000717.
Barik G, Acharya S, Sen Gupta Manideepa, Sadhukhan PC, Aich I, Chakraborty A. Comparison of HCV TRI-DOT with RNA PCR for confirmation of ELISA positive results and evaluation of a combination of ELISA and HCV TRI-DOT assay for diagnosis of HCV infection. IOSR J Den Med Sci. 2019;18(6):85-8.
El Sokkary RH, Tash RM, Meawed TE, El Seifi OS, Mortada EM. Detection of hepatitis C virus (HCV) among health care providers in an Egyptian university hospital: different diagnostic modalities. Infect Drug Resist. 2017 Oct 17;10:357-64. doi: 10.2147/IDR.S145844, PMID 29270026.
Published
How to Cite
Issue
Section
Copyright (c) 2025 SRIHARSHA N., RAJYALAKSHMI G., KASTURI P., VIJAYAKUMAR K.
This work is licensed under a Creative Commons Attribution 4.0 International License.